✦ LIBER ✦

P2-082 * THE MODIFIED PNA-LNA PCR CLAMP METHOD FOR THE DETECTION OF EGFR MUTATIONS IN NON-SMALL CELL LUNG CANCER

✍ Scribed by Tanai, C.; Ushijima, T.; Ohara, S.; Tanaka, Y.; Noda, H.; Usui, K.; Horiuchi, H.

Book ID: 121839580
Publisher: Oxford University Press
Year: 2013
Tongue: English
Weight: 25 KB
Volume: 24
Category: Article
ISSN: 0923-7534
DOI: 10.1093/annonc/mdt460.81

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Advances in Experimental Medicine and B

[Advances in Experimental Medicine and Biology] Respiratory Regulation - The Molecular Approach Volume 756 || Reliable Detection of Rare Mutations in EGFR Gene Codon L858 by PNA-LNA PCR Clamp in Non-small Cell Lung Cancer

✍ Pokorski, Mieczyslaw 📂 Article 📅 2012 🏛 Springer Netherlands ⚖ 830 KB

9019 The benefits of PCR-Invader method

9019 The benefits of PCR-Invader method for analysis of EGFR gene mutation in the primary non-small-cell lung cancer

✍ Shiina, T.; Eguchi, T.; Hyogotani, A.; Saito, G.; Hamanaka, K.; Kurai, M.; Kondo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Efficiency of the Therascreen® RGQ PCR k

Efficiency of the Therascreen® RGQ PCR kit for the detection of EGFR mutations in non-small cell lung carcinomas

✍ Vallée, Audrey; Le Loupp, Anne-Gaelle; Denis, Marc G. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 461 KB

Utility of serum DNA and pyrosequencing

Utility of serum DNA and pyrosequencing for the detection of EGFR mutations in non-small cell lung cancer

✍ Akca, Hakan; Demiray, Aydın; Yaren, Arzu; Bir, Ferda; Koseler, Aylin; Iwakawa, R 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 1001 KB

Detection of epidermal growth factor rec

Detection of epidermal growth factor receptor mutations in plasma by mutant-enriched PCR assay for prediction of the response to gefitinib in patients with non-small-cell lung cancer

✍ Chen He; Ming Liu; Chengzhi Zhou; Jiexia Zhang; Ming Ouyang; Nanshan Zhong; Jun 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 260 KB 👁 2 views

## Abstract The high frequency of epidermal growth factor receptor (__EGFR__) mutations in tyrosine kinase inhibitor‐responsive non‐small‐cell lung cancer (NSCLC) cases is now well established, highlighting the predictive value of activating __EGFR__ mutations in guiding the clinical use of __EGFR_

High resolution melting analysis for the

High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples:KRAScodon 12 and 13 mutations in non-small cell lung cancer

✍ Michael Krypuy; Genni M Newnham; David M Thomas; Matthew Conron; Alexander Dobro 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 983 KB